Adicet Capital Expenditures from 2010 to 2024

ACET Stock  USD 0.91  0.05  5.81%   
Adicet Bio Capital Expenditures yearly trend continues to be comparatively stable with very little volatility. Capital Expenditures will likely drop to about 3.7 M in 2024. From the period from 2010 to 2024, Adicet Bio Capital Expenditures quarterly data regression had r-value of  0.45 and coefficient of variation of  140.99. View All Fundamentals
 
Capital Expenditures  
First Reported
2000-03-31
Previous Quarter
302 K
Current Value
401 K
Quarterly Volatility
1.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.2 M, Interest Expense of 23.8 K or Selling General Administrative of 34.7 M, as well as many indicators such as Price To Sales Ratio of 12.57, Dividend Yield of 0.0 or PTB Ratio of 0.45. Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
  
Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Latest Adicet Bio's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Adicet Bio over the last few years. Capital Expenditures are funds used by Adicet Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Adicet Bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Adicet Bio's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adicet Bio's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

Adicet Capital Expenditures Regression Statistics

Arithmetic Mean3,497,560
Geometric Mean1,557,455
Coefficient Of Variation140.99
Mean Deviation3,452,614
Median1,098,000
Standard Deviation4,931,287
Sample Variance24.3T
Range16.7M
R-Value0.45
Mean Square Error21T
R-Squared0.20
Significance0.09
Slope493,007
Total Sum of Squares340.4T

Adicet Capital Expenditures History

20243.7 M
20234.5 M
202216.8 M
202113 M
2020990 K
20191.1 M
2018876 K

About Adicet Bio Financial Statements

Adicet Bio shareholders use historical fundamental indicators, such as Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Adicet Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Expenditures4.5 M3.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.